SOROS FUND MANAGEMENT LLC
Q3 2023 13F-HR Holdings
Net value change ($000)
+635,115
(9.9%)
New positions
71
Sold out positions
36
Turnover %
60.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AIY | 280,890 | NEW |
| Abcam plc | 139,938 | NEW |
| NVO | 138,759 | NEW |
| CRH | 113,098 | NEW |
| SPLUNK INC | 84,088 | NEW |
| ANG-PD | 71,649 | NEW |
| AER | 62,983 | 117.9% |
| DENBURY INC | 49,268 | NEW |
| Horizon Therapeutics Public Ltd Co | 42,010 | 12.4% |
| ARMK | 31,932 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| LQD | -331,948 | -96.7% |
| PDC ENERGY, INC. | -99,131 | -100.0% |
| RIVN | -69,767 | -100.0% |
| IVERIC bio, Inc. | -66,878 | -100.0% |
| ARMK | -52,724 | -100.0% |
| Focus Financial Partners Inc. | -29,325 | -100.0% |
| CE | -28,589 | -100.0% |
| VMC | -26,782 | -100.0% |
| CRH PLC | -19,506 | -100.0% |
| RNR | -12,786 | -36.7% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,154,057
(30.6% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|